tirzepatide 2023 weight-loss study shows promising results Tirzepatide (Zepbound) - Obesity treatment
Description
Supplementary material The Supplementary Material for this article can be found online at: References 1 SzczerbinskiLFlorezJC
Known serious hypersensitivity to Tirzepatide or any of the excipients in Tirzepatide
10.1016/s0140-6736(21)01443-4
One source says morning
For example, in the SURMOUNT-1 Trial, people taking Mounjaro over 72 weeks noticed an average reduction in body weight of 15% (4)
Pricing and availability may change
